Equity Components [Axis]
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Antidilutive Securities [Axis]
Stock Option
Financing Warrant
Warrant
Legal Entity [Axis]
William Noyes Webster Foundation Inc
Debt Instrument [Axis]
Interest receivable {1}
Secured Promissory Note
Contingent Consideration by Type [Axis]
Payment To Consultant
One-Seven LLC
Unfunded Portion of Note
Title of Individual [Axis]
Chief Executive Officer
Related Party [Axis]
Gerard M. Jacobs
Notes Payable to Related Parties
Financial Instrument [Axis]
Class of Warrant or Right [Axis]
Warrants 3
Warrants 1 And 2
Warrant 1
Warrant 2
Type of Arrangement and Non-arrangement Transactions [Axis]
Stock Option Agreement
Miss Mimi
Range [Axis]
Minimum
Maximum
MVJ Realty, LLC
Parere Partners Inc.
Medical marijuana on Cape Cod
Subsequent Event Type [Axis]
Subsequent Event [Member]
Independent contractor
William C. Jacobs
Document and Entity Information:
Entity Registrant Name
Document Type
Document Period End Date
Amendment Flag
Entity Central Index Key
Current Fiscal Year End Date
Entity Common Stock, Shares Outstanding
Entity Filer Category
Entity Current Reporting Status
Entity Voluntary Filers
Entity Well-known Seasoned Issuer
Document Fiscal Year Focus
Document Fiscal Period Focus
Entity Public Float
Trading Symbol
Contained File Information, File Number
Entity Incorporation, State Country Name
Entity Address, Address Line One
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Postal Zip Code
City Area Code
Local Phone Number
Statement of Financial Position [Abstract]
ASSETS
Current Assets
Cash and cash equivalents
Total Current Assets
Note receivable
Interest receivable
Total Assets
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities
Accounts Payable - Related Party
Accounts Payable - Related Party - Payable to William C. Jacobs
Accounts Payable - Related Party - Payable to Gerard M. Jacobs
Accounts Payable - Related Party - Payable to Other Related Party
Accounts Payable - Related Party
Trade accounts payable
Total Current Liabilities
Shareholders' Equity
Preferred stock, $0.001 par value; 10,000,000 shares authorized; none outstanding
Common stock, $0.001 par value; 100,000,000 shares authorized; 2,369,648 and 2,269,648 shares outstanding, respectively
Additional paid-in capital
Accumulated deficit
Total Shareholders'Equity
Total Liabilities and Shareholders' Equity
Common Stock, par or stated value
Common Stock, shares authorized
Common Stock, shares outstanding
Preferred Stock, par or stated value
Preferred Stock, shares authorized
Preferred Stock, shares issued
Preferred Stock, shares outstanding
Income Statement [Abstract]
Selling, General and Administrative Expense
Professional Fees
Bad Debt Expense
Interest Income
Other Income
Provision for Income Taxes
Net Loss
Basic and Diluted Earnings Loss per Share
Basic and diluted weighted average number of common shares outstanding:
Statement [Table]
Statement [Line Items]
Stockholders' Equity beginning of period, Value
Stockholders' Equity beginning of period, Shares
Exercise of Stock Options, Value
Exercise of Stock Options, Shares
Net Loss
Stockholders' Equity, end of period, Value
Stockholders' Equity, end of period, Shares
Statement of Cash Flows [Abstract]
Cash Flows From Operating Activities
Adjustments to Reconcile Loss to net Cash Used in Operating Activities:
Changes in operating assets and liabilities:
Bad debt expense
Prepaid expenses
Accrued interest receivable
Accounts Payable - Related Party
Trade Accounts Payable
Net Cash Used in Operating Activities
Cash Flows From Investing Activities
Notes receivable
Net Cash Provided by (Used In) Provided by Investing Activities
Cash Flow From Financing Activities
Exercise of Stock Options
Net Cash Provided by (Used in) Financing Activities
Net (Decrease) Increase in Cash
Cash and Cash Equivalents at Beginning of Year
Cash and Cash Equivalents at End of Year
Supplemental Cash Flow Information
Cash paid for interest
Cash paid for income taxes
Disclosure Text Block [Abstract]
Note 1 - Basis of Presentation and Significant Accounting Policies
Note 2 - Risks and Uncertainties
Note 3 - Notes Receivable
Related Party Transactions [Abstract]
Note 4 - Amounts Owed to Related Parties
Note 5 - Shareholders' Equity
Note 6 - Income Taxes
Note 7 - Contingent Contractual Obligations and Commercial Commitments
Subsequent Events [Abstract]
Note 8 - Subsequent Events
Policy Text Block [Abstract]
Basis of Presentation
Use of Estimates
Income Taxes
Basic and Diluted Earnings (Loss) Per Common Share
Recent Accounting Pronouncements
Table Text Block Supplement [Abstract]
Schedule of Earnings Per Share, Basic and Diluted
Schedule of Share-based Compensation, Stock Options and Warrant Activity
Schedule of Effective Income Tax Rate Reconciliation
Schedule of Deferred Tax Assets
Text Block [Abstract]
Weighted Average Shares Outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Net Cash Used in Operating Activities
Debt Instrument, Face Amount
Note receivable payment
Advances
Note Receivable
Debt Instrument, Interest Rate, Stated Percentage
Debt Instrument, Description
Non-interest bearing loan
Expense reimbursements
Fees and expense reimbursement
Stock compensation expense
Class of Warrant, Outstanding
Class of Warrant, Exercise Price of Warrants
Terms of Award
Grants in Period, Weighted Average Grant Date Total Fair Value
Grants in Period, Weighted Average Grant Date Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Method Used
Expected Future Stock Volatility
Risk Free Interest Rate
Dividend Yield
Expected Term
Minimum Capital Raise needed to fund PPV Merger
Warrants to Be Issued Upon Acquisition of Real Estate
Grants in Period, Weighted Average Grant Date Fair Value
Stock granted
Purchase price
Purchase price per share
Warrants expired
Weighted Average Remaining Contractual Term
Aggregate Intrinsic Value
Options, Outstanding, Beginning Balance
Options, Outstanding, Weighted Average Exercise Price, Beginning Balance
Exercised options
Options, Outstanding, Ending Balance
Options, Outstanding, Weighted Average Exercise Price, Ending Balance
Options, Outstanding, Weighted Average Remaining Term
Options, Outstanding, Intrinsic Value
Options, Exercisable
Options, Exercisable, Weighted Average Exercise Price
Options, Exercisable, Weighted Average Remaining Term
Options, Exercisable, Intrinsic Value
Net Operating Loss Carryforwards
Operating Loss Carryforwards, Expiration Date
Valuation Allowance, Deferred Tax Asset, Increase, Amount
Tax expenses (benefit) at statutory rate (34%)
State tax benefit, net of federal benefit
Non-deductible expenses
Revision of prior years' deferred tax assets
Change in estimated future income tax rates
Change in valuation allowance
Provision for Income Taxes
Operating loss carry forwards
Stock-based compensation
Allowance on Loan Loss
Other
Less: Valuation allowance
Net Deferred Income Tax Asset
Commitments Under Agreements with the Foundation
Debt Instrument, Face Amount
Debt Instrument, Use of proceeds
Debt Instrument, Increase
Debt Instrument, Repurchase Amount
Interest rate
Loan
Purchase of warrants
Exercise Price of Warrants
Maturity date
Debt Instrument, Use of proceeds
The minimum amount of capital that needs to be raised to fund the cash portion of the PPV merger consideration.
Grants in Period, Weighted Average Grant Date Total Fair Value
The amount of warrants that will be exercised upon the acquistion of real estate owned by entities controlled by a director of the reporting entity.
Accounts Payable - Related Party - Payable to William C. Jacobs.
Accounts Payable - Related Party - Payable to Gerard M. Jacobs.
Accounts Payable - Related Party - Payable to Other Related Party.
Allowance on loan loss.
Purchase of warrants.
Assets, Current
Assets
Accounts Payable, Related Parties, Current
Liabilities, Current
Stockholders' Equity Attributable to Parent
Liabilities and Equity
Selling, General and Administrative Expense
Professional Fees
Shares, Outstanding
Increase (Decrease) in Prepaid Expense
Increase (Decrease) in Accrued Interest Receivable, Net
Increase (Decrease) in Accounts Payable, Related Parties
Increase (Decrease) in Notes Receivable, Current
Net Cash Provided by (Used in) Investing Activities
Net Cash Provided by (Used in) Financing Activities
Cash and Cash Equivalents, Period Increase (Decrease)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance
Debt Instrument, Repurchased Face Amount